Kelly CRISPR & Gene Editing Tech ETF Stock Price, News & Analysis
xdna
NASDAQ
Company Description
Kelly CRISPR & Gene Editing Tech ETF (NASDAQ: xdna) is a publicly traded company.
xdna stock has declined 100.0% over the past year.
This page provides a comprehensive overview of xdna stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
-100%
Performance 1 year
$0.0
Kelly CRISPR & Gene Editing Tech ETF (xdna) stock. Over the past 12 months, the stock has lost 100.0%.
Latest News
Kelly CRISPR & Gene Editing Tech ETF has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all xdna news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months